Dr Irina Lyadova

Dr Lyadova is an MD and holds a PhD and DSci in immunology. She has specialised in clinical laboratory diagnostics, including immunodiagnostics. She has been working in the field of TB for more than 20 years, first in experimental TB models, and later in clinical TB. From 2008 to 2019, she was the Head of the Laboratory of Biotechnology (Central Tuberculosis Research Institute, Moscow, Russia) that focused on various aspects of TB immunology, including the immunodiagnostics of TB and latent TB infection, the search for new biomarkers for TB diagnostics/prediction and fundamental aspects of TB susceptibility and resistance. She, along with her team, have contributed to the implementation of immunological TB tests (Nikitina et al., Int J Inf Dis, 2019; Nikitina et al., J Imm Res, 2016), described several new markers of TB activity and progression (Nikitina et al., PLOS One, 2012; Tsiganov et al., JI, 2014; Panteleev et al., Front. Immunol., 2017) and suggested a role for uncontrolled inflammation in TB pathogenesis (Lyadova et al., PLOS One, 2010; Lyadova, InTech, 2012). Since 2019 Dr Lyadova heads the Laboratory of Cellular and Molecular Basis of Histogenesis (Koltzov Institute of Developmental Biology, Moscow) that focuses on the elaboration of cellular models to study immune cell development and interactions with pathogens, including mycobacteria. She is a professor and acting Head of the Department of Cellular Biomedicine (Faculty of Continuing Medical Education, Pirogov Russian National Research Medical University, Moscow). She has an analytical mind, and solving novel issues is what motivates her.